Display options
Share it on

Paediatr Anaesth. 2022 Jan;32(1):77-78. doi: 10.1111/pan.14312. Epub 2021 Oct 23.

Peripherally inserted central catheters: 100% success providing 13-day antibiotic therapy in cystic fibrosis patients aged 2 to 18 years.

Paediatric anaesthesia

Siak Lee, Christopher Brasher

Affiliations

  1. Department of Anaesthesia, Royal Children's Hospital, Melbourne, Vic., Australia.

PMID: 34637575 DOI: 10.1111/pan.14312

[No abstract available.]

Keywords: adolescent < Age; child < Age; intravenous agents < Drugs

References

  1. Döring G, Flume P, Heijerman H, Elborn JS. Treatment of lung infection in patients with cystic fibrosis: current and future strategies. J Cyst Fibros. 2012;11(6):461-479. https://doi.org/10.1016/j.jcf.2012.10.004 - PubMed
  2. Abedin S, Kapoor G. Peripherally inserted central venous catheters are a good option for prolonged venous access in children with cancer. Pediatr Blood Cancer. 2008;51(2):251-255. https://doi.org/10.1002/pbc.21344 - PubMed
  3. Bui S, Babre F, Hauchecorne S, et al. Intravenous peripherally-inserted central catheters for antibiotic therapy in children with cystic fibrosis. J Cyst Fibros. 2009;8(5):326-331. https://doi.org/10.1016/j.jcf.2009.07.002 - PubMed
  4. GmbH A. The Clavien-Dindo classification. AssesSurgery GmbH. https://www.assessurgery.com/clavien-dindo-classification/. Accessed May 1, 2021. - PubMed
  5. Thiagarajan RR, Ramamoorthy C, Gettmann T, Bratton SL. Survey of the use of peripherally inserted central venous catheters in children. Pediatrics. 1997;99(2):E4. https://doi.org/10.1542/peds.99.2.e4 - PubMed

Publication Types